Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

EGFL7 anticorps

EGFL7 Reactivité: Humain WB, IHC Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN1589809
  • Antigène Voir toutes EGFL7 Anticorps
    EGFL7 (EGF-Like-Domain, Multiple 7 (EGFL7))
    Reactivité
    • 31
    • 7
    • 4
    Humain
    Hôte
    • 23
    • 8
    • 1
    • 1
    • 1
    Lapin
    Clonalité
    • 27
    • 7
    Polyclonal
    Conjugué
    • 23
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp EGFL7 est non-conjugé
    Application
    • 20
    • 16
    • 4
    • 4
    • 3
    • 3
    • 3
    • 2
    Western Blotting (WB), Immunohistochemistry (IHC)
    Fonction
    VE-Statin/EGFL7 antibody
    Specificité
    Recombinant human EGFL-7
    Attributs du produit
    Chromosomal location: 9q34.3
    Produced from sera of rabbits immunised with highly pure recombinant human VE-Statin/EGFL-7.
    Purification
    Anti-human VE-Statin/EGFL-7 was purified by Protein-A chromatography.
    Immunogène
    Recombinant human EGFL7
    Isotype
    IgG
    Top Product
    Discover our top product EGFL7 Anticorps primaire
  • Indications d'application
    Western Blot: Use 1-5 μg/mL
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    Centrifuge vial prior to opening. Reconstitute in sterile water to a concentration of 0.1-1.0 mg/mL.
    Buffer
    PBS
    Conseil sur la manipulation
    Centrifuge vial prior to opening.
    Stock
    4 °C,-20 °C
    Stockage commentaire
    The lyophilized antibody is stable for at least 2 years at -20°C. After sterile reconstitution the antibody is stable at 2-8°C for up to 6 months. Frozen aliquots are stable for at least 6 months when stored at -20°C. Addition of a carrier protein or 50% glycerol is recommended for frozen aliquots.
    Date de péremption
    24 months
  • Antigène
    EGFL7 (EGF-Like-Domain, Multiple 7 (EGFL7))
    Autre désignation
    VE-Statin/EGFL7 (EGFL7 Produits)
    Synonymes
    anticorps egfl7, anticorps MGC53105, anticorps EGFL7, anticorps zgc:136669, anticorps zgc:152804, anticorps zneu1, anticorps xegfl7, anticorps MGC147423, anticorps VE-statin, anticorps Zneu1, anticorps NEU1, anticorps RP11-251M1.2, anticorps VE-STATIN, anticorps ZNEU1, anticorps EGF like domain multiple 7 S homeolog, anticorps EGF like domain multiple 7, anticorps EGF-like-domain, multiple 7, anticorps EGF-like domain 7, anticorps egfl7.S, anticorps EGFL7, anticorps egfl7, anticorps Egfl7
    Sujet
    EGFL7, NEU1, ZNEU1, VE-STATIN, RP11-251M1.2, NOTCH4-like protein, Vascular endothelial statin,EGFL7 (VE-Statin) is an ~ 30 kDa secreted protein that contains an Emilin-like (EMI) domain (a multimerization motif), and two epidermal growth factor (EGF) domains, one of which binds calcium. Based on these domains, it has been hypothesized that EGFL7 may self-assemble like extracellular matrix (ECM) proteins and, thus, could incorporate into ECM. EGFL7 has been reported to stimulate cell adhesion as well as motility in a manner similar to ECM proteins. EGFL7 has been shown to be primarily expressed by developing ECs but also by primordial germ cells and some central nervous system neurons. Interestingly, EGFL7 expression markedly decreases in ECs in postnatal life, but can be strongly up-regulated after various tissue injuries that lead to increased angiogenic responses.
    ID gène
    51162
    NCBI Accession
    NM_016215, NP_057299
    UniProt
    Q9UHF1
Vous êtes ici:
Support technique